Frank Ahmann

Frank Ahmann

CoFounder, President & CEO – XM Therapeutics, Inc.

With over three decades of experience in the dynamic biotech and medical device industries, this seasoned senior executive has consistently transformed visionary concepts into thriving products and enterprises. They epitomize the role of a “working leader,” seamlessly blending strategic foresight and meticulous planning with hands-on involvement across multiple domains, including research and development, operational excellence, clinical and regulatory affairs, strategic marketing, business development, financial stewardship, and executive leadership.

Their career is marked by a passion for building inspired organizations and cultivating high-performing teams dedicated to upholding the highest professional standards. Their extensive knowledge spans the realms of biologics, medical devices, and pharmaceuticals, with a specialized focus on the cardiovascular, hematology/oncology, nephrology, adoptive immunotherapy, and cell therapy sectors. Their track record underscores their proficiency in both navigating and nurturing international business landscapes, complemented by fluency in German, Spanish, and English, which enables them to forge invaluable global networks and partnerships.

Throughout their professional journey, they have consistently harnessed their multifaceted expertise to drive innovation, catalyze growth, and leave an indelible mark on the biotech and medical device industries. Their career is a testament to a relentless pursuit of excellence and an unwavering commitment to advancing the frontiers of healthcare.